The Senate Committee on Commerce, Science, and Transportation convened a hearing to examine pharmacy benefit manager (PBM) practices and their role in the pharmaceutical supply chain. The following witnesses testified that PBM anticompetitive practices negatively impact beneficiaries and community pharmacies and emphasized the need for greater transparency to shed light on which PBM practices are most detrimental. Dr. Ryan Oftebro,… (Slifer, February 16, 2023) #Pharmacies, #Pharmacy Benefit Managers, #Prescription Drugs